Professional Documents
Culture Documents
Magnesium
Sulfate
Trade Name
Martham
Minimum Dose
1-2 g qH by IV
infusion
Maximum
Dose
4-6 g qH by IV
infusion
Pharmacologic
Class
Mineral,
Electrolyte
Therapeutic
Class
Antiepileptic,
Laxative; Mineral,
electrolyte
replacement
Pregnancy Risk
Factor
A
B (Laxative)
Contents
Magnesium
sulfate
Availability
and color
- Granules- 40 mEq/5
g
- Injection- 0.325,
0.65, 1, 4 mEq/mL
Routes of
administration
Oral
Intramuscular
Intravenous
Source:
Karch, Amy: 2009
Lippincotts Nursing
Drug Guide, p. 724
Onset
1-2 hr
IM
60 min
IV
Immedia
te
Peak
unknow
n
unknow
n
unknow
n
General
Indications
- Constipation
- Torsades de
pointes
- Muscle stimulating
effects of barium
poisoning
- Reduction of
cerebral oedema.
Hypomagnesaemia
- Seizures
associated with
epilepsy,
glomerulonephritis
or hypothyroidism.
- Toxemias of
pregnancy
- Boils and
carbuncles
Duratio
n
3-4 hr
3-4 hr
Concentrations
- Allergy to magnesium
products
- Abdominal pain
- Nausea
- Vomiting
- Acute surgical abdomen
- Fecal impaction
- Intestinal and biliary tract
obstruction
- Hepatitis
- Myocardial damage
- Heart blocks
- 2 hr preceding delivery
CNS: Weakness,
drowsiness, dizziness,
fainting, sweating
Respiratory: Decreased
respiratory rate
CV: Palpitations
GI: Excessive bowel
activity, perianal irritation
Metabolic: Magnesium
intoxication,
hypocalcemia with tetany
During
- Give IM route by deep IM injection
- Monitor serum magnesium levels.
- Do not give oral MgSO4 with
abdominal pain, nausea, or
vomiting.
- Do not administer if knee-jerk
reflexes are suppressed
- Monitor bowel function.
Precaution
- Renal insufficiency
Drug interaction
Drug to drug
- Potentiation of
neuromuscular
blockade produced by
nondepolarizing
neuromuscular
relaxants
After
- Arrange to discontinue
administration as soon as levels are
within normal limits and desired
clinical response is obtained.
- Discontinue if diarrhea or
cramping occurs.
- Arrange for dietary measures,
exercise and environmental control
to return to normal bowel activity.
- Report sweating, flushing, muscle
tremors or twitching, inability to
move extremities.
- Maintain urine output at a level o
100 mL every 4 hr during parentera
administration.
Drug to food
- none reported
30 min
Source:
http://mims.com.ph/,
Karch, Amy: 2009
Lippincotts Nursing
Drug Guide, pp. 724
Source:
http://mims.com.ph/, Karch, Amy: 2009
Lippincotts Nursing Drug Guide, pp. 724-725
Source:
http://mims.com.ph/
Source:
Karch, Amy: 2009 Lippincotts
Nursing Drug Guide, pp. 724725
Before
- Assess for contraindicated
conditions.
- Monitor knee-jerk reflex before
repeated parenteral administration
- Give as laxative as temporary
measure.
- Reserve IV use in eclampsia for
life-threatening situations.
- Observe the 15 rights in drug
administration.
Source:
Karch, Amy: 2009 Lippincotts
Nursing Drug Guide, p. 725
Source:
Karch, Amy: 2009 Lippincotts Nursing Drug
Guide, pp. 725-726